The Circular RNA circFOXK2 Enhances the Tumorigenesis of Non-Small Cell Lung Cancer Through the miR-149-3p/IL-6 Axis

被引:6
作者
Xiang, Tongwei [1 ]
Chen, Liping [2 ]
Wang, Huaying [1 ]
Yu, Tao [1 ]
Li, Tang [1 ]
Li, Jipeng [2 ]
Yu, Wanjun [1 ]
机构
[1] Ningbo Univ, Yinzhou Peoples Hosp, Dept Resp & Crit Care Med, Affiliated Peoples Hosp, Ningbo 315000, Peoples R China
[2] Ningbo Univ, Yinzhou Peoples Hosp, Dept Cent Lab, Affiliated Peoples Hosp, Ningbo 315000, Peoples R China
关键词
circFOXK2; miR-149-3p; Non-small cell lung cancer; IL-6; GASTRIC-CANCER; PROGRESSION; CARCINOMAS; EXPRESSION; PROMOTE;
D O I
10.1007/s10528-023-10394-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Circular RNAs (circRNAs) are the non-coding types of RNAs and are thoughts to be linked with human cancer progression. circFOXK2 is believed to be associated with cancers, however, the molecular mechanisms of circFOXK2 in non-small cell lung cancer (NSCLC) are still unclear. Here we firstly reported that circFOXK2 enhances the tumorigenesis of NSCLC through the miR-149-3p/IL-6 axis. The expression of circFOXK2, microRNA-149-3p (miR-149-3p) and IL-6 were assessed by qRT-PCR and western blot. Transwell, colony formation, wound healing, and CCK-8 assays were used to elucidate NSCLC cells' proliferation, migration, and invasion. MiR-149-3p interaction with circFOXK2 was confirmed by dual-luciferase reporter gene assay (DLRGA). Furthermore, the biological effect of circFOXK2 on NSCLC progression was detected by tumor xenograft assay. CircFOXK2 were upregulated in NSCLC tissues and cells, miR-149-3p were downregulated in NSCLC tissues and cells. In addition, circFOXK2 stimulated NSCLC cell proliferation, migration and invasion in vitro. Mechanical analysis indicated that circFOXK2 modulated IL-6 via miR-149-3p sponging. Furthermore, circFOXK2 overexpression promoted tumor growth in vivo. Overall, this research verified that circFOXK2 enhances the tumorigenesis of NSCLC through the miR-149-3p/IL-6 axis.
引用
收藏
页码:95 / 111
页数:17
相关论文
共 52 条
[41]   CircRBM33 regulates IL-6 to promote gastric cancer progression through targeting miR-149 [J].
Wang, Ning ;
Lu, Keyu ;
Qu, Huiheng ;
Wang, Hao ;
Chen, Yigang ;
Shan, Ting ;
Ge, Xuhui ;
Wei, Yunyu ;
Zhou, Peng ;
Xia, Jiazeng .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 125
[42]   Expanding uncapped translation and emerging function of circular RNA in carcinomas and noncarcinomas [J].
Wang, Yan ;
Wu, Chunjie ;
Du, Yu ;
Li, Zhongwei ;
Li, Minle ;
Hou, Pingfu ;
Shen, Zhigang ;
Chu, Sufang ;
Zheng, Junnian ;
Bai, Jin .
MOLECULAR CANCER, 2022, 21 (01)
[43]  
Wang YF, 2020, AM J CANCER RES, V10, P1130
[44]   CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942 [J].
Wong, Chi Hin ;
Lou, Ut Kei ;
Li, Youjia ;
Chan, Stephen L. ;
Tong, Joanna H. M. ;
To, Ka-Fai ;
Chen, Yangchao .
CANCER RESEARCH, 2020, 80 (11) :2138-2149
[45]   CircRNAs in cancer metabolism: a review [J].
Yu, Tao ;
Wang, Yanfen ;
Fan, Yu ;
Fang, Na ;
Wang, Tongshan ;
Xu, Tongpeng ;
Shu, Yongqian .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
[46]   Upregulated circRNA_102231 promotes gastric cancer progression and its clinical significance [J].
Yuan, Gaofeng ;
Ding, Wenwen ;
Sun, Bingjie ;
Zhu, Lin ;
Gao, Yuewen ;
Chen, Lulu .
BIOENGINEERED, 2021, 12 (01) :4936-4945
[47]   The emerging roles of circular RNA-mediated autophagy in tumorigenesis and cancer progression [J].
Yuan, Yuan ;
Zhang, Xiaojing ;
Fan, Xinmin ;
Peng, Yin ;
Jin, Zhe .
CELL DEATH DISCOVERY, 2022, 8 (01)
[48]   Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells [J].
Zhang, Nan ;
Nan, Aruo ;
Chen, Lijian ;
Li, Xin ;
Jia, Yangyang ;
Qiu, Miaoyun ;
Dai, Xin ;
Zhou, Hanyu ;
Zhu, Jialu ;
Zhang, Han ;
Jiang, Yiguo .
MOLECULAR CANCER, 2020, 19 (01)
[49]  
Zhang W, 2021, AGING-US, V13, P18978, DOI 10.18632/aging.203347
[50]   Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis [J].
Zhang, Wei ;
Liu, Ting ;
Li, Tianshu ;
Zhao, Xudong .
CANCER GENE THERAPY, 2021, 28 (3-4) :279-293